Navigation Links
Corporate clients will dominate surge in nanotech tool demand, study projects

Corporate research and development will dominate a surge in demand for nanotech tools in the coming years, according to a study released this week by a New York consulting firm that focuses on nanotechnology.

The study, by Lux Research, also projected that sales of nanotech tools could double to $1.1 billion in five years.

"Interest in......

Full article >>> report projects:

• Inspection tools such as scanning probe microscopes and electron microscopes will experience tepid sing-digit growth as the academic market stalls and the smaller corporate base requires time to take off.

• Fabrication tools, dominated by nanoimprint lithography, will grow at double-digit rates as applications gain traction and as these tools move be......

Full article >>> resistance to change, and sales will be restricted to early adopters at universities for some time to come. These tools still represent such a small component of the market that even double-digit growth will represent small numbers for several years to come."

Lagally, who reviewed the research summary, said "the report likely underestimates the growth of inspection tools, because it is......

Full article >>>
'"/> By David Niles 09/14/05

Related biology technology :

1. Corporate Social Responsibility - Burden, sham, or golden opportunity?
2. Corporate venturing can nurture software success
3. Corporate control begins with a strong board
4. Corporate name change challenges
5. Corporate Americas hidden deficit
6. Corporate identity fitness test
7. UW Office of Corporate Relations nears one-year mile-mark
8. UW Office of Corporate Relations Celebrates Early Accomplishments
9. Sonic Foundry CEO Predicts the Corporate Enterprise Will Be the Linchpin for Rich Medias Growth Surge at Streaming Media 2003
10. Sonic Foundry gains six Mediasite clients
11. Sonic Foundry gains five university clients for Mediasite
Post Your Comments:

(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
Breaking Biology Technology:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
Breaking Biology News(10 mins):